SAB Biotherapeutics, Inc. (SABS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.71
Day's range
$3.95

SAB Biotherapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIVO CAPITAL, LLC 05/20/2026 11.42 M $43.74 M   0.00% 59.13%
CALIGAN PARTNERS LP 05/15/2026 7.97 M $30.51 M   100.00% 41.26%
PERCEPTIVE ADVISORS LLC 05/29/2026 6.43 M $24.63 M   700.75% 33.30%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 4.40 M $16.86 M   0.00% 22.79%
COMMODORE CAPITAL LP 05/15/2026 4.40 M $16.86 M   0.00% 22.79%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 3.76 M $14.40 M   690.94% 19.47%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 3.41 M $13.04 M   100.00% 17.63%
MILLENNIUM MANAGEMENT LLC 05/15/2026 3.03 M $11.62 M   835.76% 15.70%
WOODLINE PARTNERS LP 05/15/2026 2.85 M $10.92 M   0.03% 14.77%
05/15/2026 2.49 M $9.55 M   100.00% 12.91%
05/14/2026 2.20 M $8.42 M   0.00% 11.38%
SESSA CAPITAL IM, L.P. 05/15/2026 2.20 M $8.42 M   0.00% 11.38%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 1.48 M $5.67 M   100.00% 7.67%
AMERIPRISE FINANCIAL INC 05/15/2026 1.48 M $5.65 M   420.41% 7.64%
ENSIGN PEAK ADVISORS, INC 05/13/2026 1.38 M $5.27 M   100.00% 7.12%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 1.05 M $4.02 M   100.00% 5.44%
PROPEL BIO MANAGEMENT, LLC 05/14/2026 1.01 M $3.89 M   55.13% 5.24%
JEFFERIES FINANCIAL GROUP INC. 05/08/2026 903.09 K $3.46 M   55.62% 4.68%
BLACKSTONE INC. 05/15/2026 860.17 K $3.29 M   -59.87% 4.45%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 768.63 K $2.94 M   792.58% 3.98%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 575.00 K $2.20 M   100.00% 2.98%
MONASHEE INVESTMENT MANAGEMENT LLC 05/13/2026 500.00 K $1.92 M   100.00% 2.59%
MARSHALL WACE, LLP 05/15/2026 463.93 K $1.78 M   96.20% 2.40%
AWM INVESTMENT COMPANY, INC. 05/15/2026 400.00 K $1.53 M   100.00% 2.07%
DV TRADING LLC 05/15/2026 400.00 K $1.53 M   100.00% 2.07%
STEMPOINT CAPITAL LP 05/18/2026 375.00 K $1.44 M   155.87% 1.94%
HB WEALTH MANAGEMENT, LLC 04/27/2026 307.50 K $1.18 M   0.00% 1.59%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 302.04 K $1.16 M   152.71% 1.56%
BLACKROCK, INC. 05/13/2026 301.33 K $1.15 M   1,647.93% 1.56%
SEVEN GRAND MANAGERS, LLC 05/06/2026 275.00 K $1.05 M   100.00% 1.42%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 197.62 K $756.88 K   100.00% 1.02%
SIMPLIFY ASSET MANAGEMENT INC. 04/27/2026 187.23 K $717.09 K   -10.08% 0.97%
TWO SIGMA INVESTMENTS, LP 05/15/2026 181.19 K $693.94 K   100.00% 0.94%
GOLDMAN SACHS GROUP INC 05/15/2026 113.94 K $436.39 K   121.90% 0.59%
06/04/2026 100.00 K $383.00 K   100.00% 0.52%
STATE STREET CORP 05/15/2026 74.23 K $284.31 K   465.70% 0.38%
JANE STREET GROUP, LLC 05/12/2026 72.10 K $276.14 K   100.00% 0.37%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 69.73 K $267.07 K   252.36% 0.36%
KESTRA ADVISORY SERVICES, LLC 04/30/2026 61.74 K $236.47 K   434.55% 0.32%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 59.16 K $226.59 K   100.00% 0.31%
NORTHERN TRUST CORP 05/14/2026 57.43 K $219.94 K   249.90% 0.30%
BANK OF AMERICA CORP /DE/ 05/18/2026 55.70 K $213.32 K   424.80% 0.29%
PATHSTONE HOLDINGS, LLC 05/11/2026 50.65 K $193.99 K   0.00% 0.26%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 50.00 K $191.50 K   100.00% 0.26%
UBS GROUP AG 05/05/2026 46.62 K $178.57 K   530.21% 0.24%
FIFTH LANE CAPITAL, LP 05/15/2026 46.50 K $178.10 K   210.00% 0.24%
COMMONWEALTH EQUITY SERVICES, LLC 04/27/2026 46.46 K $177.92 K   100.00% 0.24%
CITADEL ADVISORS LLC 05/15/2026 42.90 K $164.31 K   100.00% 0.22%
VIRTU FINANCIAL LLC 05/14/2026 37.94 K $145.00 K   100.00% 0.20%
AMERICAN CENTURY COMPANIES INC 05/15/2026 37.46 K $143.45 K   100.00% 0.19%

SAB Biotherapeutics Inc institutional Ownership - FAQ's

During the previous two years, 83 institutional investors and hedge funds held shares of SAB Biotherapeutics Inc. The most heavily invested institutionals were:

Vivo Capital, LLC: 11.42 M

Caligan Partners LP: 7.97 M

PERCEPTIVE ADVISORS LLC: 6.43 M

RA CAPITAL MANAGEMENT, L.P.: 4.4 M

COMMODORE CAPITAL LP: 4.4 M

BALYASNY ASSET MANAGEMENT L.P.: 3.76 M

358.29% of SAB Biotherapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 67.30 M shares in the last 24 months. This purchase volume represents approximately $258.44 M in transactions.